Ibrar A. Siddique

New Delhi, DL 110067, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Osteocalcin modulates Abeta42 aggregation to aid in amyloid reduction in mouse models of Alzheimer's disease.

Osteocalcin modulates Abeta42 aggregation to aid in amyloid reduction in mouse models of Alzheimer's disease.

Journal: Experimental neurology

Published: December 17, 2024

Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA.

Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 03, 2024

ARL6IP5 Ameliorates α-Synuclein Burden by Inducing Autophagy via Preventing Ubiquitination and Degradation of ATG12.

ARL6IP5 Ameliorates α-Synuclein Burden by Inducing Autophagy via Preventing Ubiquitination and Degradation of ATG12.

Journal: International journal of molecular sciences

Published: May 14, 2023

Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological Samples.

Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological Samples.

Journal: ACS chemical neuroscience

Published: March 15, 2023

Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications.

Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications.

Journal: Pharmacological reviews

Published: May 26, 2022

mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.

mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: October 26, 2021

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.

Journal: Alzheimer's research & therapy

Published: April 23, 2021

Lysine-selective molecular tweezers are cell penetrant and concentrate in lysosomes.

Lysine-selective molecular tweezers are cell penetrant and concentrate in lysosomes.

Journal: Communications biology

Published: February 02, 2021

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.

Journal: Alzheimer's research & therapy

Published: September 25, 2020

Different Inhibitors of Aβ42-Induced Toxicity Have Distinct Metal-Ion Dependency.

Different Inhibitors of Aβ42-Induced Toxicity Have Distinct Metal-Ion Dependency.

Journal: ACS chemical neuroscience

Published: June 20, 2020

An insight into the inhibition of fibrillation process verses disaggregation of preformed fibrils of bovine serum albumin by isoprenaline hydrochloride.

An insight into the inhibition of fibrillation process verses disaggregation of preformed fibrils of bovine serum albumin by isoprenaline hydrochloride.

Journal: International journal of biological macromolecules

Published: May 29, 2019

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.

Journal: Nature communications

Published: May 09, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026